Influence of Single Nucleotide Polymorphisms of Carboxypeptidase D (CPD) Gene on Body Weight and Fat Mass Reduction by Perindopril in Obese Subjects: A Phase II, Multicenter, Double-blind Study
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2017
At a glance
- Drugs Perindopril (Primary)
- Indications Obesity
- Focus Biomarker; Therapeutic Use
- Sponsors Gene PreDiT
- 18 May 2017 New trial record
- 11 May 2017 Planned patients number has been changed from 160 to 139.
- 11 May 2017 Status changed from recruiting to discontinued.